Cationic Defence Peptides Show Variable Effect on Antimicrobial and Anticancer Efficacy

Cationic defence peptides, a type of antimicrobial and anticancer agent, have been shown to have therapeutic potential. However, the role of C-terminal amidation in their efficacy has been unclear. A study by Dennison and colleagues analyzed the toxicity of these peptides to normal fibroblast cells, various tumour cells, and bacterial cells, revealing a variable effect on their antimicrobial and anticancer efficacy.

Key Takeaways:

• The study investigated the effect of C-terminal amidation on the efficacy and selectivity of antimicrobial and anticancer peptides.
• Researchers analyzed the toxicity of a series of C-terminally amidated defence peptides and their non-amidated isoforms.
• The results showed that C-terminal amidation had a variable effect on the antimicrobial and anticancer efficacy of the peptides.
• The study challenged previous claims based on analysis of single amidation events.
• The researchers tested the peptides on normal fibroblast cells, various tumour cells, and bacterial cells.

Statistics:

• The study was published in Molecular and Cellular Biochemistry.
• The research was conducted by Dennison and colleagues.
• The study analyzed 43-50 tampaire moderately inhibited by tdp analogue tmp authors
• The research was supported by University of Central Lancashire, School Pharmacy & Pharmaceutical Science.
• The study found that C-terminal amidation had no clear effect on the selectivity of the peptides for different cell types.

Sources:

• Dennison and colleagues, "The effect of C-terminal amidation on the efficacy and selectivity of antimicrobial and anticancer peptides. Molecular and Cellular Biochemistry, 2009;332(1-2):43-50"
• University of Central Lancashire, School Pharmacy & Pharmaceutical Science
• Molecular and Cellular Biochemistry
• Cancer Weekly editors and reports / NewsRx.com